Education
About Us
Working with TipRanks
Follow Us
Teladoc (TDOC)
NYSE:TDOC
TDOC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.76 - $15.27
Previous CloseN/A
Volume1.13M
Average Volume (3M)8.62M
Market Cap
$1.41B
Enterprise Value$1.86B
Total Cash (Recent Filing)$1.30B
Total Debt (Recent Filing)$1.58B
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Apr 23, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.88
Shares Outstanding173,672,030
10 Day Avg. Volume5,012,906
30 Day Avg. Volume8,618,461
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.57
Price to Cash Flow (P/CF)4.30
P/FCF Ratio3.90
Enterprise Value/Market Cap1.32
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.02
Enterprise Value/Ebitda-3.16
Forecast
1Y Price Target
$10.91Price Target Upside34.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
---
Bulls Say, Bears Say
Bulls Say
Growth InitiativesTeladoc is taking the right steps to accelerate growth through initiatives like the Catapult Health acquisition and partnerships with companies like Amazon.
International GrowthThe company has international growth potential and stable paying user numbers in BetterHelp, indicating upward stock opportunity.
Program ExpansionTeladoc announced expansion of its Comprehensive Weight Care program which now includes a new relationship to provide lower cost, self-pay access to GLP-1 medicine.
Bears Say
Client LossThere is a loss of a chronic care health plan client in the second quarter, which dampens expected growth.
Profitability IssuesThe estimated decline in BetterHelp's adjusted EBITDA by 22% year-over-year suggests challenges in maintaining profitability.
Revenue ChallengesWeak BetterHelp MAUs could point to softer 1Q revenue.
---
Ownership Overview
0.88% Insiders
16.87% Mutual Funds
9.61% Other Institutional Investors
55.57% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $6.76 and its highest was $15.27 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $1.41B.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Apr 23, 2025 which is in 23 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Feb 26, 2025. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.26 by -$0.02.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.34.
How many shares outstanding does Teladoc have?
Teladoc has 173,672,030 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.26. Following the earnings report the stock price went down -13.558%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in TDOC
---
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.91 (34.86% Upside)
$10.91 (34.86% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 73%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.3%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.42%
12-Months-Change
Fundamentals
Return on Equity
-52.46%
Trailing 12-Months
Asset Growth
-19.98%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
---
TDOC Company Deck
---
TDOC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view with significant growth in membership and international expansion, counterbalanced by revenue declines and challenges in BetterHelp and health plan channels. The company acknowledged headwinds but also highlighted strategic priorities and growth areas.Read More>---
TDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
---
TDOC Stock 12 Month Forecast
Average Price Target
$10.91
▲(34.86% Upside)
Technical Analysis
National Healthcare
―
Phreesia
―
Arcutis Biotherapeutics
―
Schrodinger
―
Enliven Therapeutics
―
Best Analysts Covering TDOC
1 Year
1 Year Success Rate
23/47 ratings generated profit
1 Year Average Return
+18.76%
reiterated a buy rating 26 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 48.94% of your transactions generating a profit, with an average return of +18.76% per trade.
---